Main > ONCOLOGY (**) > Colon Cancer>MET>MSI-H * > Treatment > USA. B. NivoluMAb>



USA. B. NivoluMAb>'s subsections
(*) USA Approval Date: 2017. 08.01
>Progressed Following Treat with>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2018. 10.16.
PR Web-Site
TradeMark
TradeMark Web-Site
UpDate: 2017. 08.18

USA. B. NivoluMAb>'s products
This section has no products